FDA accepts Opus Genetics presbyopia drug application
Go back to FDA accepts Opus Genetics presbyopia drug application| Diversified Corporate Resources, Inc. (NASDAQ: IRD) | Delayed: 4.20 +0.37 (9.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.83 | 52 Week High | $0.02 | |||
| Open | $3.86 | 52 Week Low | $0.02 | |||
| Day High | $4.29 | P/E | N/A | |||
| Day Low | $3.86 | EPS | $0.00 | |||
| Volume | 476,157 | |||||
